01 / 20

Chronic Liver Disease
and Cirrhosis Care

From compensated fibrosis to decompensation: recognizing complications, scoring severity, and managing the cirrhotic patient.

USMLE Step 3

What Is Cirrhosis?

Cirrhosis is the irreversible end stage of chronic liver injury: ongoing inflammation drives fibrosis (scarring) and the formation of regenerative nodules that distort normal architecture.

This scarring blocks blood flow through the liver, raising the pressure in the portal venous system and impairing the liver's synthetic and detoxifying functions.

Common Etiologies

Alcohol
Chronic heavy intake; \( \text{AST:ALT ratio} > 2 \).
Viral Hepatitis
Chronic hepatitis C and B are leading global causes.
MASLD / NASH
Metabolic-associated steatotic liver disease; obesity, diabetes.
Autoimmune
Autoimmune hepatitis, PBC, PSC.
Genetic / Metabolic
Hemochromatosis, Wilson disease, α1-antitrypsin deficiency.

The Engine: Portal Hypertension

Scarred Liver Portal vein
\( \uparrow \) Pressure
Backup of blood \( \rightarrow \) collaterals open
Varices Ascites Splenomegaly

Compensated vs Decompensated

The single most important clinical distinction. Decompensation is defined by the appearance of any major complication, and it dramatically shifts prognosis.

CompensatedDecompensated
SymptomsOften asymptomaticSymptomatic
Hallmark eventsNone yetAscites, variceal bleed, encephalopathy, jaundice
Median survival> 12 years~ 2 years
GoalPrevent decompensationTreat complications, transplant eval

Scoring Severity

Child-Pugh (A/B/C)
5 variables: bilirubin, albumin, INR, ascites, encephalopathy. Predicts surgical risk and survival.
MELD / MELD-Na
Uses bilirubin, INR, creatinine (+ sodium). Prioritizes transplant allocation.

The Core Complication Cascade

1
Varices & bleeding. Screen with EGD; prevent with nonselective beta-blockers or band ligation.
2
Ascites. Sodium restriction + diuretics (spironolactone + furosemide). Watch for SBP.
3
Hepatic encephalopathy. Driven by ammonia; treat with lactulose ± rifaximin.
4
Hepatorenal syndrome (HRS). Functional renal failure; albumin + vasoconstrictors.
5
Hepatocellular carcinoma (HCC). Surveillance with ultrasound every 6 months.

Spontaneous Bacterial Peritonitis

Any cirrhotic with ascites who develops fever, abdominal pain, or worsening encephalopathy needs a diagnostic paracentesis.

Add IV albumin (\( 1.5 \ \text{g/kg} \) day 1, \( 1 \ \text{g/kg} \) day 3) to reduce the risk of HRS. After an episode, give long-term antibiotic prophylaxis.

Key Distinction: SAAG

The serum-ascites albumin gradient tells you whether ascites is from portal hypertension or another cause: $$ \text{SAAG} = \text{Serum albumin} - \text{Ascitic albumin} $$

SAAG \( \geq 1.1 \)SAAG \( < 1.1 \)
MechanismPortal hypertensionNon-portal
ExamplesCirrhosis, heart failure, Budd-ChiariMalignancy, TB, pancreatitis

A Stepwise Approach

1
Confirm and stage. History, exam, labs, imaging; calculate Child-Pugh and MELD.
2
Identify decompensation. Ascites, bleeding, encephalopathy, or jaundice?
3
Treat active complications. Paracentesis, antibiotics, lactulose, transfusion as needed.
4
Prevent recurrence. Beta-blockers, diuretics, SBP prophylaxis.
5
Surveillance & referral. HCC ultrasound q6 months; transplant evaluation if MELD high.

Worked Example: New Ascites

A 55-year-old man with alcohol use disorder presents with progressive abdominal distension. Exam shows shifting dullness. Paracentesis: serum albumin 3.5, ascitic albumin 1.0, PMN 90.

Management: dietary sodium restriction, start spironolactone + furosemide, counsel alcohol cessation, and arrange HCC surveillance.

Worked Example: Variceal Bleed

A 60-year-old woman with cirrhosis vomits bright red blood. BP 88/52, HR 118. She is confused.

1
Resuscitate: two large-bore IVs, restrictive transfusion to \( \text{Hgb} \approx 7 \ \text{g/dL} \).
2
Pharmacology: IV octreotide + IV antibiotics (ceftriaxone) for all bleeders.
3
Definitive: urgent EGD with band ligation within 12 hours.

Worked Example: Encephalopathy

A cirrhotic patient is brought in confused with asterixis. Family notes recent constipation and missed lactulose doses.

Management: restart lactulose titrated to 2–3 soft stools daily, add rifaximin if recurrent, correct the precipitant. Do not excessively restrict protein.

Common Mistakes

✕ Skipping paracentesis
Any cirrhotic with ascites and deterioration needs fluid analysis to rule out SBP.
✕ Over-transfusing bleeds
Aggressive transfusion raises portal pressure and worsens bleeding. Target \( \text{Hgb} \approx 7 \).
✕ Restricting protein
Protein restriction in encephalopathy promotes catabolism; treat ammonia instead.
✕ Forgetting albumin in SBP
IV albumin reduces hepatorenal syndrome and mortality alongside antibiotics.
✕ Missing HCC surveillance
All cirrhotics need ultrasound every 6 months regardless of symptoms.

Complication Quick Reference

ComplicationKey TestFirst-Line Treatment
VaricesEGD screeningBeta-blocker / band ligation
AscitesSAAG, paracentesisNa restriction + diuretics
SBPPMN \( \geq 250 \)Cefotaxime + albumin
EncephalopathyClinical, ammoniaLactulose ± rifaximin
HRSCr rise, exclude othersAlbumin + vasoconstrictors
HCCUS q6 monthsResection / transplant / ablation

Question 1 of 5

A cirrhotic with ascites develops fever and abdominal pain. Paracentesis shows ascitic PMN of \( 480 \ \text{cells/mm}^3 \). What is the best next step?

Question 2 of 5

A patient has serum albumin 3.6 g/dL and ascitic albumin 2.8 g/dL. What does the SAAG suggest?

Question 3 of 5

A cirrhotic presents with active variceal bleeding. Besides resuscitation and endoscopy, which therapy reduces mortality?

Question 4 of 5

A confused cirrhotic with asterixis is found to be constipated. What is the first-line treatment for the hepatic encephalopathy?

Question 5 of 5

An asymptomatic patient with compensated cirrhosis asks about cancer screening. What surveillance is recommended?